UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas

European journal of cancer (1990), 2002-03, Vol.38 (4), p.543-549

2002

Volltextzugriff (PDF)

Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial

Journal of clinical oncology, 2005-01, Vol.23 (3), p.576-584

2005

Volltextzugriff (PDF)

Hypoxia in human soft tissue sarcomas : adverse impact on survival and no association with p53 mutations

British journal of cancer, 2001-04, Vol.84 (8), p.1070-1075

2001

Volltextzugriff (PDF)

Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients

European journal of cancer (1990), 2002-12, Vol.38 (18), p.2397-2406

2002

Volltextzugriff (PDF)

Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy

European journal of cancer (1990), 2003, Vol.39 (1), p.64-69

2003

Volltextzugriff (PDF)

Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

European journal of cancer (1990), 2002-03, Vol.38 (4), p.556-559

2002

Volltextzugriff (PDF)

Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

European journal of cancer (1990), 2000, Vol.36 (1), p.61-67

2000

Volltextzugriff (PDF)

Bone metastases: pathophysiology and management policy

Journal of clinical oncology, 1991-03, Vol.9 (3), p.509-524

1991

Volltextzugriff (PDF)

Exatecan in pretreated adult patients with advanced soft tissue sarcoma: Results of a phase II – Study of the EORTC Soft Tissue and Bone Sarcoma Group

European journal of cancer (1990), 2007-04, Vol.43 (6), p.1017-1022

2007

Volltextzugriff (PDF)

High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group

British journal of cancer, 1998-12, Vol.78 (12), p.1634-1639

1998

Volltextzugriff (PDF)

Prognostic factors in soft tissue sarcomas: The Aarhus experience

European journal of cancer (1990), 1998-11, Vol.34 (12), p.1876-1882

1998

Volltextzugriff (PDF)

Imatinib mesylate (STI-571 Glivec®, Gleevec™) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target: Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study

European journal of cancer (1990), 2003-09, Vol.39 (14), p.2006-2011

2003

Volltextzugriff (PDF)

Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group

Journal of clinical oncology, 1996-04, Vol.14 (4), p.1146-1155

1996

Volltextzugriff (PDF)

Coarse grain models and the computer simulation of soft materials

Journal of physics. Condensed matter, 2004-04, Vol.16 (15), p.R481-R512

2004

Volltextzugriff (PDF)

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)

Annals of oncology, 2015-05, Vol.26 (5), p.865-872

2015

Volltextzugriff (PDF)

Elevated serum insulin-like growth factor-binding protein 2 (IGDBP-2) and decreased IGFBP-3 in epithelial ovarian cancer : Correlation with cancer antigen 125 and tumor-associated trypsin inhibitor

The journal of clinical endocrinology and metabolism, 1997-07, Vol.82 (7), p.2308-2313

1997

Volltextzugriff (PDF)

Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx®) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas

European journal of cancer (1990), 2006-09, Vol.42 (14), p.2303-2309

2006

Volltextzugriff (PDF)

The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas

International journal of radiation oncology, biology, physics, 1996-07, Vol.35 (4), p.701-708

1996

Volltextzugriff (PDF)

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

The Lancet (British edition), 2001-10, Vol.358 (9291), p.1421-1423

2001

Volltextzugriff (PDF)

Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

European journal of cancer (1990), 1999-03, Vol.35 (3), p.410-412

1999

Volltextzugriff (PDF)

Preoperative and postoperative irradiation of soft tissue sarcomas: Effect on radiation field size

International journal of radiation oncology, biology, physics, 1991-11, Vol.21 (6), p.1595-1599

1991

Volltextzugriff (PDF)

In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: mutual relationship and correlation with clinical data

British journal of cancer, 1999-03, Vol.79 (7-8), p.1074-1084

1999

Volltextzugriff (PDF)

Soft-tissue sarcoma of the thigh: Surgical margin influences local recurrence but not survival in 152 patients

Acta orthopaedica, 2001, Vol.72 (1), p.72-77

2001

Volltextzugriff (PDF)

Time-course of the hazard of murine nephropathy induced by total-body irradiation

International journal of radiation biology, 2000, Vol.76 (7), p.979-983

Safwat, S. M. Bentzen, O. S. Nielsen, J. Overgaard, A.

2000

Volltextzugriff (PDF)

Intradermal and subcutaneous leiomyosarcoma: a clinicopathological and immunohistochemical study of 41 cases

Journal of cutaneous pathology, 1996-10, Vol.23 (5), p.458-463

1996

Volltextzugriff (PDF)

1 – 25 von 10.681

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(8.586)
Mit Volltextzugriff
(8.475)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

11 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(6.394)
Life Sciences & Biomedicine
(4.487)
Humans
(3.450)
Female
(2.197)
Male
(2.117)
Biological And Medical Sciences
(1.905)
Adult
(1.527)
Physical Sciences
(1.512)
Middle Aged
(1.475)
Medical Sciences
(1.333)
Animals
(1.094)
Aged
(986)
Technology
(880)
Physics
(796)
Chemistry
(680)
Fundamental And Applied Biological Sciences. Psychology
(654)
Exact Sciences And Technology
(619)
Adolescent
(524)
Biochemistry & Molecular Biology
(456)
Engineering
(404)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(4.633)
Ingenta
(3.901)
EZB Electronic Journals Library
(3.501)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(3.175)
Elsevier ScienceDirect Journals Complete
(1.919)
Wiley Online Library All Journals
(1.766)
Publisher or Other Site
(1.683)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.665)
IngentaConnect Journals
(1.600)
Wiley Online Library
(1.251)
Springer Journals
(849)
Ebook Central Perpetual and DDA
(709)
eBooks on EBSCOhost
(692)
Taylor & Francis Current Content Access
(579)
Oxford journals
(548)
Taylor & Francis Journals
(548)
Taylor & Francis Journals
(538)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(530)
Jstor Complete Legacy
(461)
Oxford Journals 2020 Medicine
(340)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(36)
... seit 30 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas

Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial

Hypoxia in human soft tissue sarcomas : adverse impact on survival and no association with p53 mutations

Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients

Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy

Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

Bone metastases: pathophysiology and management policy

Exatecan in pretreated adult patients with advanced soft tissue sarcoma: Results of a phase II – Study of the EORTC Soft Tissue and Bone Sarcoma Group

High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group

Prognostic factors in soft tissue sarcomas: The Aarhus experience

Imatinib mesylate (STI-571 Glivec®, Gleevec™) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target: Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study

Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group

Coarse grain models and the computer simulation of soft materials

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)

Elevated serum insulin-like growth factor-binding protein 2 (IGDBP-2) and decreased IGFBP-3 in epithelial ovarian cancer : Correlation with cancer antigen 125 and tumor-associated trypsin inhibitor

Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx®) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas

The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

Preoperative and postoperative irradiation of soft tissue sarcomas: Effect on radiation field size

In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: mutual relationship and correlation with clinical data

Soft-tissue sarcoma of the thigh: Surgical margin influences local recurrence but not survival in 152 patients

Time-course of the hazard of murine nephropathy induced by total-body irradiation

Intradermal and subcutaneous leiomyosarcoma: a clinicopathological and immunohistochemical study of 41 cases

Suchergebnisse filtern